Literature DB >> 22381937

Breast cancer in Brazil: present status and future goals.

Brittany L Lee1, Pedro Er Liedke, Carlos H Barrios, Sergio D Simon, Dianne M Finkelstein, Paul E Goss.   

Abstract

Breast cancer is the most common cancer in women worldwide and 70% of breast cancer deaths occur in women from low-income and middle-income countries. Latin America has about 115,000 new cases of disease every year, with about 50,000 arising in Brazil. We examined the present status of breast cancer in Brazil as an example of the health effects of geographical, ethnic, and socioeconomic diversities on delivery of care. Our goal was to identify deficiencies that could be responsible for disparities in survival from breast cancer. We searched the English and Portuguese published work and reviewed national databases and Brazilian publications. Although the availability of publications specific to Brazil is low in general, we identified several factors that could account for disparities: delays in diagnosis due to low cancer awareness and implementation of mammography screening, unknown quality of surgery, and restricted access to radiotherapy and modern systemic therapies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381937     DOI: 10.1016/S1470-2045(11)70323-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  48 in total

1.  Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital.

Authors:  Lorena Rocha Ayres; Marília Silveira de Almeida Campos; Thais de Oliveira Gozzo; Edson Zangiacomi Martinez; Andrea Queiróz Ungari; Jurandyr Moreira de Andrade; Leonardo Régis Leira Pereira
Journal:  Int J Clin Pharm       Date:  2015-01-31

2.  Initial care and outcome of glioblastoma multiforme patients in 2 diverse health care scenarios in Brazil: does public versus private health care matter?.

Authors:  Luiz Victor Maia Loureiro; Lucíola de Barros Pontes; Donato Callegaro-Filho; Ludmila de Oliveira Koch; Eduardo Weltman; Elivane da Silva Victor; Adrialdo José Santos; Lia Raquel Rodrigues Borges; Roberto Araújo Segreto; Suzana Maria Fleury Malheiros
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

3.  Translating genomics: cancer genetics, public health and the making of the (de)molecularised body in Cuba and Brazil.

Authors:  Sahra Gibbon
Journal:  Hist Cienc Saude Manguinhos       Date:  2016 Jan-Mar

Review 4.  Current Status of Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer.

Authors:  Tomás Reinert; Rodrigo Gonçalves; Matthew J Ellis
Journal:  Curr Treat Options Oncol       Date:  2018-04-16

Review 5.  Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.

Authors:  Fei Pan; Hui Mao; Ling Deng; Guangchao Li; Peiliang Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.

Authors:  Maggie C U Cheang; K David Voduc; Dongsheng Tu; Shan Jiang; Samuel Leung; Stephen K Chia; Lois E Shepherd; Mark N Levine; Kathleen I Pritchard; Sherri Davies; Inge J Stijleman; Carole Davis; Mark T W Ebbert; Joel S Parker; Matthew J Ellis; Philip S Bernard; Charles M Perou; Torsten O Nielsen
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

7.  Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective.

Authors:  Marcio Machado; Thomas R Einarson
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-11-13

8.  Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience.

Authors:  Otto Metzger-Filho; Evandro de Azambuja; Ian Bradbury; Kamal S Saini; José Bines; Sergio D Simon; Veerle Van Dooren; Gursel Aktan; Kathleen I Pritchard; Antonio C Wolff; Ian Smith; Christian Jackisch; Istvan Lang; Michael Untch; Frances Boyle; Binghe Xu; Jose Baselga; Edith A Perez; Martine Piccart-Gebhart
Journal:  Oncologist       Date:  2013-01-28

9.  Cervical and female breast cancers in the Americas: current situation and opportunities for action.

Authors:  Silvana Luciani; Anna Cabanes; Elisa Prieto-Lara; Vilma Gawryszewski
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

10.  Bevacizumab as first-line therapy in advanced non-small-cell lung cancer: a brazilian center experience.

Authors:  Denis Leonardo Fontes Jardim; Débora de Melo Gagliato; Karina Braga Ribeiro; Andrea Kazumi Shimada; Artur Katz
Journal:  Drugs R D       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.